Infant respiratory distress syndrome
(Redirected from Hyaline membrane disease)
Jump to navigation
Jump to search
Infantile respiratory distress syndrome (IRDS), also called respiratory distress syndrome of newborn, or increasingly surfactant deficiency disorder (SDD),[1] and previously called hyaline membrane disease (HMD), is a syndrome in premature infants caused by developmental insufficiency of pulmonary surfactant production and structural immaturity in the lungs.[2][3] IRDS affects about 1% of newborns and is the leading cause of death in preterm infants.[4]
References
- ↑ Northway Jr, WH. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. The New England Journal of Medicine 276 (7) (Feb 16, 1967). p. 357–68. doi:10.1056/NEJM196702162760701.
- ↑ Santosham, Mathuram. Risk of Early-Onset Neonatal Infection with Maternal Infection or Colonization: A Global Systematic Review and Meta-Analysis. PLOS Medicine 10 (8) (2013). p. e1001502. doi:10.1371/journal.pmed.1001502.
- ↑ Sinha, Sunil. Essential neonatal medicine (2012). Chichester, West Sussex: John Wiley & Sons. ISBN 9780470670408.
- ↑ Neonatal-perinatal medicine: diseases of the fetus and infant (2002). St. Louis: Mosby. p. 1001–1011. ISBN 978-0-323-00929-4.
